SSIM
MREO

Sheets Smith Investment Management’s Mereo BioPharma MREO Stock Holding History

Sheets Smith Investment Management’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$34.8K Hold
16,890
– – 0.02% 136
2025
Q2 		$45.8K Hold
16,890
– – 0.04% 69
2025
Q1 		$38K Hold
16,890
– – 0.04% 41
2024
Q4 		$59.1K Buy
+16,890
New +$66.4K 0.05% 55

Other funds holding MREO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sheets Smith Investment Management's MREO Position: Q3 2025 in Review

Sheets Smith Investment Management held its Mereo BioPharma (MREO) position steady in Q3 2025 at 16,890 shares worth $34.8K. The position accounts for 0.02% of the portfolio, ranked #136.

Sheets Smith Investment Management first reported a position in MREO in Q4 2024 and has held it in 4 quarters since. The position peaked at $59.1K in Q4 2024. 84 funds tracked by Wall St. Rank hold MREO as of Q3 2025.

  • Sheets Smith Investment Management held 16,890 shares of Mereo BioPharma worth $34.8K as of Q3 2025.
  • Sheets Smith Investment Management left its Mereo BioPharma share count unchanged in Q3 2025.
  • Mereo BioPharma made up 0.02% of Sheets Smith Investment Management's portfolio in Q3 2025, its #136 holding.
  • Sheets Smith Investment Management first reported a position in Mereo BioPharma in Q4 2024 and has held it in 4 quarters since.
  • Sheets Smith Investment Management's Mereo BioPharma position peaked at $59.1K in Q4 2024.
  • 84 funds tracked by Wall St. Rank held Mereo BioPharma as of Q3 2025.

Based on Sheets Smith Investment Management's 13F filing for Q3 2025, filed 8 Oct 2025.